Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 318

1.

Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.

Dalbeth N, Phipps-Green A, Frampton C, Neogi T, Taylor WJ, Merriman TR.

Ann Rheum Dis. 2018 Feb 20. pii: annrheumdis-2017-212288. doi: 10.1136/annrheumdis-2017-212288. [Epub ahead of print]

PMID:
29463518
2.

The Cost-effectiveness of Biannual Serum Urate (SU) Monitoring after Reaching Target in Gout: A Health Economic Analysis Comparing SU Monitoring.

Robinson PC, Dalbeth N, Donovan P.

J Rheumatol. 2018 Feb 15. pii: jrheum.170199. doi: 10.3899/jrheum.170199. [Epub ahead of print]

PMID:
29449500
3.

An association of smoking with serum urate and gout: A health paradox.

Fanning N, Merriman TR, Dalbeth N, Stamp LK.

Semin Arthritis Rheum. 2017 Nov 22. pii: S0049-0172(17)30524-3. doi: 10.1016/j.semarthrit.2017.11.004. [Epub ahead of print] Review.

PMID:
29398126
4.

Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis.

Wallace MC, Roberts RL, Nanavati P, Miner JN, Dalbeth N, Topless R, Merriman TR, Stamp LK.

Rheumatology (Oxford). 2018 Jan 12. doi: 10.1093/rheumatology/kex467. [Epub ahead of print]

PMID:
29342288
5.

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.

Wright DFB, Dalbeth N, Phipps-Green AJ, Merriman TR, Barclay ML, Drake J, Tan P, Horne A, Stamp LK.

Br J Clin Pharmacol. 2018 Jan 17. doi: 10.1111/bcp.13516. [Epub ahead of print]

PMID:
29341237
6.

Imaging tools to measure treatment response in gout.

Dalbeth N, Doyle AJ.

Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i27-i34. doi: 10.1093/rheumatology/kex445.

PMID:
29272513
7.

The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2017 Dec 21;19(1):283. doi: 10.1186/s13075-017-1491-x.

8.

Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.

Stamp LK, Morillon MB, Taylor WJ, Dalbeth N, Singh JA, Lassere M, Christensen R.

J Rheumatol. 2017 Dec 15. pii: jrheum.170911. doi: 10.3899/jrheum.170911. [Epub ahead of print]

PMID:
29247147
9.

Mitochondrial genetic variation and gout in Māori and Pacific people living in Aotearoa New Zealand.

Gosling AL, Boocock J, Dalbeth N, Harré Hindmarsh J, Stamp LK, Stahl EA, Choi HK, Matisoo-Smith EA, Merriman TR.

Ann Rheum Dis. 2017 Dec 15. pii: annrheumdis-2017-212416. doi: 10.1136/annrheumdis-2017-212416. [Epub ahead of print]

PMID:
29247128
10.

Footwear interventions for foot pain, function, impairment and disability for people with foot and ankle arthritis: A literature review.

Frecklington M, Dalbeth N, McNair P, Gow P, Williams A, Carroll M, Rome K.

Semin Arthritis Rheum. 2017 Nov 3. pii: S0049-0172(17)30590-5. doi: 10.1016/j.semarthrit.2017.10.017. [Epub ahead of print] Review.

11.

"What say ye gout experts?" a content analysis of questions about gout posted on the social news website Reddit.

Derksen C, Serlachius A, Petrie KJ, Dalbeth N.

BMC Musculoskelet Disord. 2017 Nov 23;18(1):488. doi: 10.1186/s12891-017-1856-y.

12.

Validation of a Definition of Flare in Patients With Established Gout.

Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hernández-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, Amorim RBC, Uhlig T, Hammer HB, Eliseev M, Perez-Ruiz F, Cavagna L, McCarthy GM, Stamp LK, Gerritsen M, Fana V, Sivera F, Taylor W.

Arthritis Rheumatol. 2017 Nov 21. doi: 10.1002/art.40381. [Epub ahead of print]

PMID:
29161469
13.

Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol.

Dalbeth N, Nicolaou S, Baumgartner S, Hu J, Fung M, Choi HK.

Ann Rheum Dis. 2018 Mar;77(3):364-370. doi: 10.1136/annrheumdis-2017-212046. Epub 2017 Nov 16.

14.

Lesinurad for the treatment of hyperuricaemia in people with gout.

Robinson PC, Dalbeth N.

Expert Opin Pharmacother. 2017 Dec;18(17):1875-1881. doi: 10.1080/14656566.2017.1401609. Epub 2017 Nov 13.

PMID:
29103339
15.

Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis.

McQueen FM, Chapman P, Pollock T, D'Souza D, Lee AC, Dalbeth N, Stamp L, Lindsay K, Doyle A.

Arthritis Res Ther. 2017 Oct 24;19(1):241. doi: 10.1186/s13075-017-1433-7.

16.

Analysis of data collected from right and left limbs: Accounting for dependence and improving statistical efficiency in musculoskeletal research.

Stewart S, Pearson J, Rome K, Dalbeth N, Vandal AC.

Gait Posture. 2018 Jan;59:182-187. doi: 10.1016/j.gaitpost.2017.10.018. Epub 2017 Oct 16.

PMID:
29054045
17.

Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.

Tausche AK, Alten R, Dalbeth N, Kopicko J, Fung M, Adler S, Bhakta N, Storgard C, Baumgartner S, Saag K.

Rheumatology (Oxford). 2017 Dec 1;56(12):2170-2178. doi: 10.1093/rheumatology/kex350.

PMID:
29029210
18.

Lack of Evidence that Soluble Urate Directly Influences Bone Remodelling: A Laboratory and Clinical Study.

Dalbeth N, Pool B, Chhana A, Lin JM, Tay ML, Tan P, Callon KE, Naot D, Horne A, Drake J, Gamble GD, Reid IR, Grey A, Stamp LK, Cornish J.

Calcif Tissue Int. 2018 Jan;102(1):73-84. doi: 10.1007/s00223-017-0328-6. Epub 2017 Oct 10.

PMID:
29018897
19.

Effects of Febuxostat in Early Gout: A Randomized, Double-Blind, Placebo-Controlled Study.

Dalbeth N, Saag KG, Palmer WE, Choi HK, Hunt B, MacDonald PA, Thienel U, Gunawardhana L.

Arthritis Rheumatol. 2017 Dec;69(12):2386-2395. doi: 10.1002/art.40233.

20.

Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study.

Dalbeth N, Allan J, Gamble GD, Phipps-Green A, Flynn TJ, Mihov B, Horne A, Doughty R, Stamp LK, Merriman TR.

RMD Open. 2017 Apr 11;3(1):e000424. doi: 10.1136/rmdopen-2016-000424. eCollection 2017.

21.

Reporting of conflicts of interest in oral presentations at medical conferences: a delegate-based prospective observational study.

Grey A, Avenell A, Dalbeth N, Stewart F, Bolland MJ.

BMJ Open. 2017 Sep 21;7(9):e017019. doi: 10.1136/bmjopen-2017-017019.

22.

An illness by any other name: The effect of renaming gout on illness and treatment perceptions.

Petrie KJ, MacKrill K, Derksen C, Dalbeth N.

Health Psychol. 2018 Jan;37(1):37-41. doi: 10.1037/hea0000548. Epub 2017 Aug 24.

PMID:
28836797
23.

Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Ann Rheum Dis. 2017 Dec;76(12):2065-2070. doi: 10.1136/annrheumdis-2017-211873. Epub 2017 Aug 22.

PMID:
28830881
24.

Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).

Dalbeth N, Bardin T, Doherty M, Lioté F, Richette P, Saag KG, So AK, Stamp LK, Choi HK, Terkeltaub R.

Nat Rev Rheumatol. 2017 Sep;13(9):561-568. doi: 10.1038/nrrheum.2017.126. Epub 2017 Aug 10. Review.

PMID:
28794514
25.

Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank.

Cadzow M, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2017 Aug 9;19(1):181. doi: 10.1186/s13075-017-1390-1.

26.

Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort.

Otter SJ, Rohan M, Davies KA, Kumar S, Gow P, Dalbeth N, Corkill M, Panthakalam S, Rome K.

J Foot Ankle Res. 2017 Jul 26;10:33. doi: 10.1186/s13047-017-0217-2. eCollection 2017.

27.

Ultrasound Characteristics of the Achilles Tendon in Tophaceous Gout: A Comparison with Age- and Sex-matched Controls.

Carroll M, Dalbeth N, Allen B, Stewart S, House T, Boocock M, Frampton C, Rome K.

J Rheumatol. 2017 Oct;44(10):1487-1492. doi: 10.3899/jrheum.170203. Epub 2017 Aug 1.

PMID:
28765249
28.

The patient experience of musculoskeletal imaging tests for investigation of inflammatory arthritis: a mixed-methods study.

Bourke S, Taylor WJ, Doyle AJ, Gott M, Dalbeth N.

Clin Rheumatol. 2017 Jul 20. doi: 10.1007/s10067-017-3760-0. [Epub ahead of print]

PMID:
28730270
29.

Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout.

Rasheed H, Stamp LK, Dalbeth N, Merriman TR.

Arthritis Res Ther. 2017 Jul 5;19(1):161. doi: 10.1186/s13075-017-1369-y.

30.

Clinically-evident tophi are associated with reduced muscle force in the foot and ankle in people with gout: a cross-sectional study.

Stewart S, Dalbeth N, Otter S, Gow P, Kumar S, Rome K.

J Foot Ankle Res. 2017 Jun 19;10:25. doi: 10.1186/s13047-017-0207-4. eCollection 2017.

31.

Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.

Dalbeth N, Jones G, Terkeltaub R, Khanna D, Kopicko J, Bhakta N, Adler S, Fung M, Storgard C, Baumgartner S, Perez-Ruiz F.

Arthritis Rheumatol. 2017 Sep;69(9):1903-1913. doi: 10.1002/art.40159. Epub 2017 Aug 4.

32.

The genetics of gout: towards personalised medicine?

Dalbeth N, Stamp LK, Merriman TR.

BMC Med. 2017 May 31;15(1):108. doi: 10.1186/s12916-017-0878-5. Review.

33.

Are ultrasound features at the first metatarsophalangeal joint associated with clinically-assessed pain and function? A study of people with gout, asymptomatic hyperuricaemia and normouricaemia.

Stewart S, Dalbeth N, Vandal AC, Allen B, Miranda R, Rome K.

J Foot Ankle Res. 2017 May 22;10:22. doi: 10.1186/s13047-017-0203-8. eCollection 2017.

34.

ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches.

Cleophas MC, Joosten LA, Stamp LK, Dalbeth N, Woodward OM, Merriman TR.

Pharmgenomics Pers Med. 2017 Apr 20;10:129-142. doi: 10.2147/PGPM.S105854. eCollection 2017. Review.

35.

Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritis.

Janssens HJEM, Fransen J, Janssen M, Neogi T, Schumacher HR, Jansen TL, Dalbeth N, Taylor WJ.

Rheumatology (Oxford). 2017 Aug 1;56(8):1335-1341. doi: 10.1093/rheumatology/kex164.

PMID:
28431109
36.

Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.

Tanner C, Boocock J, Stahl EA, Dobbyn A, Mandal AK, Cadzow M, Phipps-Green AJ, Topless RK, Hindmarsh JH, Stamp LK, Dalbeth N, Choi HK, Mount DB, Merriman TR.

Arthritis Rheumatol. 2017 Jul;69(7):1461-1469. doi: 10.1002/art.40110. Epub 2017 May 31.

PMID:
28371506
37.

Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout.

Vazirpanah N, Kienhorst LBE, Van Lochem E, Wichers C, Rossato M, Shiels PG, Dalbeth N, Stamp LK, Merriman TR, Janssen M, Radstake TRDJ, Broen JC.

Ann Rheum Dis. 2017 Jul;76(7):1313-1319. doi: 10.1136/annrheumdis-2016-210538. Epub 2017 Mar 27.

PMID:
28347991
38.

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout.

Stamp LK, Chapman PT, Barclay ML, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Ann Rheum Dis. 2017 Sep;76(9):1522-1528. doi: 10.1136/annrheumdis-2016-210872. Epub 2017 Mar 17.

PMID:
28314755
39.

Advanced imaging assessment of gout: comparison of dual-energy CT and MRI with anatomical pathology.

Chhana A, Doyle A, Sevao A, Amirapu S, Riordan P, Dray M, McGlashan S, Cornish J, Dalbeth N.

Ann Rheum Dis. 2017 Mar 10. pii: annrheumdis-2017-211343. doi: 10.1136/annrheumdis-2017-211343. [Epub ahead of print] No abstract available.

PMID:
28283513
40.

Population-specific association between ABCG2 variants and tophaceous disease in people with gout.

He W, Phipps-Green A, Stamp LK, Merriman TR, Dalbeth N.

Arthritis Res Ther. 2017 Mar 7;19(1):43. doi: 10.1186/s13075-017-1254-8.

41.

Medical specialists' attitudes to prescribing biosimilars.

Hemmington A, Dalbeth N, Jarrett P, Fraser AG, Broom R, Browett P, Petrie KJ.

Pharmacoepidemiol Drug Saf. 2017 May;26(5):570-577. doi: 10.1002/pds.4186. Epub 2017 Feb 24.

PMID:
28233367
42.

Foot involvement in systemic lupus erythematosus: more than joint disease?

Rome K, Dalbeth N, Jarrett P, Kumar S, Carroll M, Clendon A, Gow P.

Clin Exp Rheumatol. 2017 May-Jun;35(3):550. Epub 2017 Jan 27. No abstract available.

PMID:
28134089
43.

Plasma oxypurinol as a measure of adherence in clinical trials.

Stamp LK, Merriman T, Frampton C, Zhang M, Wallace M, Miner JN, Dalbeth N.

Ann Rheum Dis. 2018 Feb;77(2):313-314. doi: 10.1136/annrheumdis-2016-210661. Epub 2017 Jan 5. No abstract available.

PMID:
28057666
44.

Dietary Management of Gout: What is the Evidence?

Kulasegaran T, Dalbeth N.

Am J Med. 2017 Jan;130(1):e37. doi: 10.1016/j.amjmed.2016.08.045. No abstract available.

PMID:
27986240
45.

Predictors of Mortality in People with Recent-onset Gout: A Prospective Observational Study.

Vincent ZL, Gamble G, House M, Knight J, Horne A, Taylor WJ, Dalbeth N.

J Rheumatol. 2017 Mar;44(3):368-373. doi: 10.3899/jrheum.160596. Epub 2016 Dec 15.

PMID:
27980010
46.

We read spam a lot: prospective cohort study of unsolicited and unwanted academic invitations.

Grey A, Bolland MJ, Dalbeth N, Gamble G, Sadler L.

BMJ. 2016 Dec 14;355:i5383. doi: 10.1136/bmj.i5383.

47.

Severe gout: Strategies and innovations for effective management.

Pascual E, Andrés M, Vázquez-Mellado J, Dalbeth N.

Joint Bone Spine. 2017 Oct;84(5):541-546. doi: 10.1016/j.jbspin.2016.10.004. Epub 2016 Dec 5.

PMID:
27932279
48.

GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes.

Nakayama A, Nakaoka H, Yamamoto K, Sakiyama M, Shaukat A, Toyoda Y, Okada Y, Kamatani Y, Nakamura T, Takada T, Inoue K, Yasujima T, Yuasa H, Shirahama Y, Nakashima H, Shimizu S, Higashino T, Kawamura Y, Ogata H, Kawaguchi M, Ohkawa Y, Danjoh I, Tokumasu A, Ooyama K, Ito T, Kondo T, Wakai K, Stiburkova B, Pavelka K, Stamp LK, Dalbeth N; Eurogout Consortium, Sakurai Y, Suzuki H, Hosoyamada M, Fujimori S, Yokoo T, Hosoya T, Inoue I, Takahashi A, Kubo M, Ooyama H, Shimizu T, Ichida K, Shinomiya N, Merriman TR, Matsuo H; Eurogout Consortium.

Ann Rheum Dis. 2017 May;76(5):869-877. doi: 10.1136/annrheumdis-2016-209632. Epub 2016 Nov 29.

49.

Lack of direct evidence for natural selection at the candidate thrifty gene locus, PPARGC1A.

Cadzow M, Merriman TR, Boocock J, Dalbeth N, Stamp LK, Black MA, Visscher PM, Wilcox PL.

BMC Med Genet. 2016 Nov 15;17(1):80.

50.

Crystal identification of synovial fluid aspiration by polarized light microscopy. An online test suggesting that our traditional rheumatologic competence needs renewed attention and training.

Berendsen D, Neogi T, Taylor WJ, Dalbeth N, Jansen TL.

Clin Rheumatol. 2017 Mar;36(3):641-647. doi: 10.1007/s10067-016-3461-0. Epub 2016 Nov 11.

PMID:
27837341

Supplemental Content

Loading ...
Support Center